PKCβII acts downstream of chemoattractant receptors and mTORC2 to regulate cAMP production and myosin II activity in neutrophils

Molecular Biology of the Cell

Volumn 25, Issue 9, 2014, Pages 1446-1457

  Liu, Lunhua ^a   Gritz, Derek ^a   Parent, Carole A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ADENYLATE CYCLASE; ADENYLYL CYCLASE 9; CPG 53353; CYCLIC AMP; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MYOSIN II; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 2; PROTEIN KINASE C INHIBITOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; 4,5-DIANILINOPHTHALIMIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR; MULTIPROTEIN COMPLEX; PHTHALIMIDE DERIVATIVE; PRKCB2 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; HYDROPHOBICITY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICAL PHENOMENA; ENZYMOLOGY; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; PROTEIN TRANSPORT; SECOND MESSENGER;

ADENYLATE CYCLASE; CELL MEMBRANE; CHEMOTAXIS, LEUKOCYTE; CYCLIC AMP; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MULTIPROTEIN COMPLEXES; MYOSIN TYPE II; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PHOSPHORYLATION; PHTHALIMIDES; PROTEIN KINASE C BETA; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECEPTORS, FORMYL PEPTIDE; SECOND MESSENGER SYSTEMS; TOR SERINE-THREONINE KINASES;

EID: 84899670900     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-01-0037     Document Type: Article

References (64)

1. Bagorda A, Mihaylov VA, Parent CA (2006). Chemotaxis: moving forward and holding on to the past. Thromb Haemost 95, 12-21.
2. Balasubramanian N, Advani SH, Zingde SM (2002). Protein kinase C isoforms in normal and leukemic neutrophils: altered levels in leukemic neutrophils and changes during myeloid maturation in chronic myeloid leukemia. Leuk Res 26, 67-81.
3. Behn-Krappa A, Newton AC (1999). The hydrophobic phosphorylation motif of conventional protein kinase C is regulated by autophosphorylation. Curr Biol 9, 728-737.
4. Bol GF, Gros C, Hulster A, Bosel A, Pfeuffer T (1997a). Phorbol ester-induced sensitisation of adenylyl cyclase type II is related to phosphorylation of threonine 1057. Biochem Biophys Res Commun 237, 251-256.
5. Bol GF, Hulster A, Pfeuffer T (1997b). Adenylyl cyclase type II is stimulated by PKC via C-terminal phosphorylation. Biochim Biophys Acta 1358, 307-313.
6. Cai H, Das S, Kamimura Y, Long Y, Parent CA, Devreotes PN (2010). Ras-mediated activation of the TORC2-PKB pathway is critical for chemotaxis. J Cell Biol 190, 233-245.
7. Charest PG, Shen Z, Lakoduk A, Sasaki AT, Briggs SP, Firtel RA (2010). A Ras signaling complex controls the RasC-TORC2 pathway and directed cell migration. Dev Cell 18, 737-749.
8. Chen Y, Harry A, Li J, Smit MJ, Bai X, Magnusson R, Pieroni JP, Weng G, Iyengar R (1997). Adenylyl cyclase 6 is selectively regulated by protein kinase A phosphorylation in a region involved in Gas stimulation. Proc Natl Acad Sci USA 94, 14100-14104.
9. Choi EJ, Wong ST, Dittman AH, Storm DR (1993). Phorbol ester stimulation of the type I and type III adenylyl cyclases in whole cells. Biochemistry 32, 1891-1894.
10. Coletta A, Pinney JW, Solis DY, Marsh J, Pettifer SR, Attwood TK (2010). Low-complexity regions within protein sequences have position-dependent roles. BMC Syst Biol 4, 43.
11. Cybulski N, Hall MN (2009). TOR complex 2: a signaling pathway of its own. Trends Biochem Sci 34, 620-627.
12. Facchinetti V et al. (2008). The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J 27, 1932-1943.
13. Feng X, Becker KP, Stribling SD, Peters KG, Hannun YA (2000). Regulation of receptor-mediated protein kinase C membrane trafficking by autophosphorylation. J Biol Chem 275, 17024-17034.
14. Freeley M, Kelleher D, Long A (2011). Regulation of protein kinase C function by phosphorylation on conserved and non-conserved sites. Cell Signal 23, 753-762.
15. Gan X, Wang J, Su B, Wu D (2011). Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 286, 10998-11002.
16. Gan X, Wang J, Wang C, Sommer E, Kozasa T, Srinivasula S, Alessi D, Offermanns S, Simon MI, Wu D (2012). PRR5L degradation promotes mTORC2-mediated PKC-d phosphorylation and cell migration downstream of Ga12. Nat Cell Biol 14, 686-696.
17. Gao T, Newton AC (2002). The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C. J Biol Chem 277, 31585-31592.
18. Gay JC, Stitt ES (1990). Chemotactic peptide enhancement of phorbol ester-induced protein kinase C activity in human neutrophils. J Leukoc Biol 47, 49-59.
19. Gould CM, Newton AC (2008). The life and death of protein kinase C. Curr Drug Targets 9, 614-625.
20. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ, Sabatini DM (2006). Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11, 859-871.
21. Gulati N, Karsy M, Albert L, Murali R, Jhanwar-Uniyal M (2009). Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Int J Oncol 35, 731-740.
22. Hernandez-Negrete I, Carretero-Ortega J, Rosenfeldt H, Hernandez-Garcia R, Calderon-Salinas JV, Reyes-Cruz G, Gutkind JS, Vazquez-Prado J (2007). P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration. J Biol Chem 282, 23708-23715.
23. Hocevar BA, Fields AP (1991). Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. J Biol Chem 266, 28-33.
24. Hurley JH (1999). Structure, mechanism, and regulation of mammalian adenylyl cyclase. J Biol Chem 274, 7599-7602.
25. Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL (2008). Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J 27, 1919-1931.
26. Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, Hall MN (2004). Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6, 1122-1128.
27. Jacinto E, Lorberg A (2008). TOR regulation of AGC kinases in yeast and mammals. Biochem J 410, 19-37.
28. Jacobowitz O, Chen J, Premont RT, Iyengar R (1993). Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment. J Biol Chem 268, 3829-3832.
29. Jacobowitz O, Iyengar R (1994). Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc Natl Acad Sci USA 91, 10630-10634.
30. Jin T, Xu X, Hereld D (2008). Chemotaxis, chemokine receptors and human disease. Cytokine 44, 1-8.
31. Kamimura Y, Xiong Y, Iglesias PA, Hoeller O, Bolourani P, Devreotes PN (2008). PIP3-independent activation of TORC2 and PKB at the cell?s leading edge mediates chemotaxis. Curr Biol 18, 1034-1043.
32. Kim EK et al. (2011). Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis. Oncogene 30, 2954-2963.
33. Lee S, Comer FI, Sasaki A, McLeod IX, Duong Y, Okumura K, Yates JR 3rd, Parent CA, Firtel RA (2005). TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium. Mol Biol Cell 16, 4572-4583.
34. Lee S, Parent CA, Insall R, Firtel RA (1999). A novel Ras-interacting protein required for chemotaxis and cyclic adenosine monophosphate signal relay in Dictyostelium. Mol Biol Cell 10, 2829-2845.
35. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ (1998). Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042-2045.
36. Liu L, Aerbajinai W, Ahmed SM, Rodgers GP, Angers S, Parent CA (2012). Radil controls neutrophil adhesion and motility through b2-integrin activation. Mol Biol Cell 23, 4751-4765.
37. Liu L, Das S, Losert W, Parent CA (2010). mTORC2 regulates neutrophil chemotaxis in a cAMP- and RhoA-dependent fashion. Dev Cell 19, 845-857.
38. Liu L, Parent CA (2011). TOR kinase complexes and cell migration. J Cell Biol 194, 815-824.
39. Majumdar S, Rossi MW, Fujiki T, Phillips WA, Disa S, Queen CF, Johnston RBJr, Rosen OM, Corkey BE, Korchak HM (1991). Protein kinase C isotypes and signaling in neutrophils. Differential substrate specificities of a translocatable calcium- and phospholipid-dependent b-protein kinase C and a phospholipid-dependent protein kinase which is inhibited by long chain fatty acyl coenzyme A. J Biol Chem 266, 9285-9294.
40. Murray NR, Burns DJ, Fields AP (1994). Presence of a bII protein kinase C-selective nuclear membrane activation factor in human leukemia cells. J Biol Chem 269, 21385-21390.
41. Nalefski EA, Newton AC (2001). Membrane binding kinetics of protein kinase C betaII mediated by the C2 domain. Biochemistry 40, 13216-13229.
42. Newton AC (2003). Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370, 361-371.
43. Newton AC (2010). Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 298, E395-E402.
44. Oancea E, Meyer T (1998). Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell 95, 307-318.
45. Oh WJ, Jacinto E (2011). mTOR complex 2 signaling and functions. Cell Cycle 10, 2305-2316.
46. Pascale A, Alkon DL, Grimaldi M (2004). Translocation of protein kinase C-betaII in astrocytes requires organized actin cytoskeleton and is not accompanied by synchronous RACK1 relocation. Glia 46, 169-182.
47. Pearce LR, Komander D, Alessi DR (2010). The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol 11, 9-22.
48. Rogue P, Labourdette G, Masmoudi A, Yoshida Y, Huang FL, Huang KP, Zwiller J, Vincendon G, Malviya AN (1990). Rat liver nuclei protein kinase C is the isozyme type II. J Biol Chem 265, 4161-4165.
49. Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K, Parker PJ (2010). PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol 11, 103-112.
50. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2004). Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14, 1296-1302.
51. Sengupta S, Peterson TR, Sabatini DM (2010). Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40, 310-322.
52. Shen JX, Wachten S, Halls ML, Everett KL, Cooper DM (2012). Muscarinic receptors stimulate AC2 by novel phosphorylation sites, whereas Gbg subunits exert opposing effects depending on the G-protein source. Biochem J 447, 393-405.
53. Smallwood JI, Malawista SE (1992). Protein kinase C isoforms in human neutrophil cytoplasts. J Leukoc Biol 51, 84-92.
54. Spudich A, Meyer T, Stryer L (1992). Association of the beta isoform of protein kinase C with vimentin filaments. Cell Motil Cytoskeleton 22, 250-256.
55. Steinberg SF (2008). Structural basis of protein kinase C isoform function. Physiol Rev 88, 1341-1378.
56. Tesmer JJ, Sprang SR (1998). The structure, catalytic mechanism and regulation of adenylyl cyclase. Curr Opin Struct Biol 8, 713-719.
57. Traxler P, Furet P, Mett H, Buchdunger E, Meyer T, Lydon N (1997). Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R. J Pharm Belg 52, 88-96.
58. Tucker KA, Lilly MB, Heck L Jr, Rado TA (1987). Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 70, 372-378.
59. Van Haastert PJ, Devreotes PN (2004). Chemotaxis: signalling the way forward. Nat Rev Mol Cell Biol 5, 626-634.
60. Wang F (2009). The signaling mechanisms underlying cell polarity and chemotaxis. Cold Spring Harb Perspect Biol 1, a002980.
61. Wei J, Wayman G, Storm DR (1996). Phosphorylation and inhibition of type III adenylyl cyclase by calmodulin-dependent protein kinase II in vivo. J Biol Chem 271, 24231-24235.
62. Yoshimura M, Cooper DM (1993). Type-specific stimulation of adenylylcyclase by protein kinase C. J Biol Chem 268, 4604-4607.
63. Zinzalla V, Stracka D, Oppliger W, Hall MN (2011). Activation of mTORC2 by association with the ribosome. Cell 144, 757-768.
64. Zoncu R, Efeyan A, Sabatini DM (2011). mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12, 21-35.